Revelation Biosciences (REVB) Research & Development (2021 - 2026)
Revelation Biosciences' Research & Development came in at $1.92 million for Q2 2026, up 45.6% from $1.32 million a year earlier and up 39.3% from the prior quarter.
Powered by 
Analysis
Revelation Biosciences (REVB) Research & Development (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Revelation Biosciences reported Research & Development of $5.18 million, up 43.4% year-over-year; for FY2025, it came in at $4.06 million, up 14.5% from FY2024.
- Research & Development carries a four-year compound annual growth rate of -12.4% (FY2021 to FY2025).
- Going back by year, Research & Development was $3.55 million in FY2024 (-14.4%), $4.15 million in FY2023 (-22.9%), $5.38 million in FY2022 (-22.2%) and $6.91 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Research & Development since Q1 2022.
- Year-over-year, Research & Development has increased for four consecutive quarters, with growth averaging 12.2% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in Q3 2023 (growth of 332.8%), and the weakest in Q4 2022 (a decline of 87.2%).
- Business Quant data shows REVB's Research & Development at $1.38 million (Q1 2026), $964,190 (Q4 2025) and $922,857 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Revelation Biosciences | 13.21 Mn | -35.81 Mn | - | 1.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.92 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 964,190.00 |
| Sep 30, 2025 | 922,857.00 |
| Jun 30, 2025 | 1.32 Mn |
| Mar 31, 2025 | 858,830.00 |
| Dec 31, 2024 | 605,504.00 |
| Sep 30, 2024 | 830,981.00 |
| Jun 30, 2024 | 1.39 Mn |
| Mar 31, 2024 | 717,582.00 |
| Dec 31, 2023 | 1.06 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 909,278.00 |
| Mar 31, 2023 | 525,273.00 |
| Dec 31, 2022 | 339,971.00 |
| Sep 30, 2022 | 381,566.00 |
| Jun 30, 2022 | 975,583.00 |
| Mar 31, 2022 | 3.68 Mn |
| Dec 31, 2021 | 2.67 Mn |
| Sep 30, 2021 | 1.53 Mn |
API Access
Revelation Biosciences Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();